Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05277207 · ClinicalTrials.gov registry record · Phase 4
Tobacco Cessation Treatment Preferences Among Veteran Smokers
A Phase 4 study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT05277207: Completed Phase 4 study, sponsored by VA Office of Research and Development.
NCT05277207 is a Phase 4 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05277207, a Phase 4 study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
There are significant barriers to tobacco cessation treatment for patients and providers in specialty care clinical settings. Specialty providers cite several barriers to delivering evidence-based tobacco cessation care, including insufficient time and lack of training. In addition, a large proportion of patients who begin tobacco cessation treatment do not quit. Use of healthcare technology (i.e., telehealth, electronic health record, and computerized treatment algorithms based on patient data) to improve patients' ability to quit tobacco use. The purpose of this study is to demonstrate the feasibility of a larger trial, and to evaluate the acceptability of the intervention design. Thirty participants will be assigned to receive either 1) a treatment that includes personalized counseling, tobacco cessation medications, and text messaging; or 2) referral to Department of Veterans Affairs' Quitline program plus SmokefreeVET, a text messaging program.
Interventions
- BEHAVIORAL VA Quitline
- BEHAVIORAL Personalized Smoking Cessation Facilitation Meetings
- DRUG Personalized Smoking Cessation Pharmacotherapy
- BEHAVIORAL Personalized Text Messaging Support
- BEHAVIORAL SmokefreeVET
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-05-02 |
| Est. Completion | 2023-09-27 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05277207
The ClinicalTrials.gov registry entry for NCT05277207 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which VA Quitline is the first listed.
NCT05277207 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05277207 about?
NCT05277207 is a clinical study titled "Tobacco Cessation Treatment Preferences Among Veteran Smokers". There are significant barriers to tobacco cessation treatment for patients and providers in specialty care clinical settings. Specialty providers cite several barriers to delivering evidence-based tobacco cessation care, including insufficient time and lack of training. In addition, a large proporti...
What is the current status of trial NCT05277207?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2022-05-02. Estimated completion is 2023-09-27.
What interventions are being tested in trial NCT05277207?
The interventions under investigation include: VA Quitline (BEHAVIORAL), Personalized Smoking Cessation Facilitation Meetings (BEHAVIORAL), Personalized Smoking Cessation Pharmacotherapy (DRUG), Personalized Text Messaging Support (BEHAVIORAL), SmokefreeVET (BEHAVIORAL).
Who is sponsoring clinical trial NCT05277207?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.